Logo image of CRCT

CRICUT INC - CLASS A (CRCT) Stock Fundamental Analysis

NASDAQ:CRCT - Nasdaq - US22658D1000 - Common Stock - Currency: USD

5.66  +0.01 (+0.18%)

After market: 5.66 0 (0%)

Fundamental Rating

6

Overall CRCT gets a fundamental rating of 6 out of 10. We evaluated CRCT against 63 industry peers in the Household Durables industry. CRCT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CRCT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CRCT had positive earnings in the past year.
In the past year CRCT had a positive cash flow from operations.
Each year in the past 5 years CRCT has been profitable.
Of the past 5 years CRCT 4 years had a positive operating cash flow.
CRCT Yearly Net Income VS EBIT VS OCF VS FCFCRCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

CRCT has a better Return On Assets (9.95%) than 80.95% of its industry peers.
With an excellent Return On Equity value of 23.25%, CRCT belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
The Return On Invested Capital of CRCT (17.73%) is better than 96.83% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRCT is in line with the industry average of 10.42%.
The last Return On Invested Capital (17.73%) for CRCT is above the 3 year average (9.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.95%
ROE 23.25%
ROIC 17.73%
ROA(3y)7.54%
ROA(5y)12.63%
ROE(3y)10.84%
ROE(5y)24.18%
ROIC(3y)9.7%
ROIC(5y)21.39%
CRCT Yearly ROA, ROE, ROICCRCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

CRCT has a better Profit Margin (10.09%) than 82.54% of its industry peers.
In the last couple of years the Profit Margin of CRCT has grown nicely.
CRCT's Operating Margin of 11.86% is fine compared to the rest of the industry. CRCT outperforms 74.60% of its industry peers.
In the last couple of years the Operating Margin of CRCT has remained more or less at the same level.
The Gross Margin of CRCT (52.14%) is better than 92.06% of its industry peers.
In the last couple of years the Gross Margin of CRCT has grown nicely.
Industry RankSector Rank
OM 11.86%
PM (TTM) 10.09%
GM 52.14%
OM growth 3Y-9.61%
OM growth 5Y-0.51%
PM growth 3Y-6.41%
PM growth 5Y1.82%
GM growth 3Y12.23%
GM growth 5Y11.09%
CRCT Yearly Profit, Operating, Gross MarginsCRCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

CRCT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CRCT has less shares outstanding than it did 1 year ago.
CRCT has less shares outstanding than it did 5 years ago.
CRCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CRCT Yearly Shares OutstandingCRCT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CRCT Yearly Total Debt VS Total AssetsCRCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

CRCT has an Altman-Z score of 3.46. This indicates that CRCT is financially healthy and has little risk of bankruptcy at the moment.
CRCT has a Altman-Z score (3.46) which is in line with its industry peers.
There is no outstanding debt for CRCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.46
ROIC/WACC2
WACC8.88%
CRCT Yearly LT Debt VS Equity VS FCFCRCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.52 indicates that CRCT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.52, CRCT is doing worse than 74.60% of the companies in the same industry.
A Quick Ratio of 1.21 indicates that CRCT should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.21, CRCT is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The current and quick ratio evaluation for CRCT is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.21
CRCT Yearly Current Assets VS Current LiabilitesCRCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2

3. Growth

3.1 Past

CRCT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.45%.
CRCT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.11% yearly.
CRCT shows a decrease in Revenue. In the last year, the revenue decreased by -3.98%.
The Revenue has been growing slightly by 7.93% on average over the past years.
EPS 1Y (TTM)6.45%
EPS 3Y-23.19%
EPS 5Y10.11%
EPS Q2Q%22.22%
Revenue 1Y (TTM)-3.98%
Revenue growth 3Y-18.29%
Revenue growth 5Y7.93%
Sales Q2Q%2.48%

3.2 Future

The Earnings Per Share is expected to decrease by -3.97% on average over the next years.
Based on estimates for the next years, CRCT will show a decrease in Revenue. The Revenue will decrease by -0.44% on average per year.
EPS Next Y-17.34%
EPS Next 2Y-10.7%
EPS Next 3Y-3.97%
EPS Next 5YN/A
Revenue Next Year-4.46%
Revenue Next 2Y-1.68%
Revenue Next 3Y-0.44%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRCT Yearly Revenue VS EstimatesCRCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CRCT Yearly EPS VS EstimatesCRCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.15, which indicates a rather expensive current valuation of CRCT.
Compared to the rest of the industry, the Price/Earnings ratio of CRCT is on the same level as its industry peers.
CRCT is valuated rather cheaply when we compare the Price/Earnings ratio to 26.93, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 24.47 indicates a rather expensive valuation of CRCT.
65.08% of the companies in the same industry are cheaper than CRCT, based on the Price/Forward Earnings ratio.
CRCT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 35.31, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.15
Fwd PE 24.47
CRCT Price Earnings VS Forward Price EarningsCRCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRCT is valued a bit cheaper than 79.37% of the companies in the same industry.
95.24% of the companies in the same industry are more expensive than CRCT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.76
EV/EBITDA 6.71
CRCT Per share dataCRCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The excellent profitability rating of CRCT may justify a higher PE ratio.
A cheap valuation may be justified as CRCT's earnings are expected to decrease with -3.97% in the coming years.
PEG (NY)N/A
PEG (5Y)1.7
EPS Next 2Y-10.7%
EPS Next 3Y-3.97%

3

5. Dividend

5.1 Amount

CRCT has a Yearly Dividend Yield of 3.60%. Purely for dividend investing, there may be better candidates out there.
CRCT's Dividend Yield is rather good when compared to the industry average which is at 3.33. CRCT pays more dividend than 87.30% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, CRCT pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.6%

5.2 History

CRCT has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CRCT Yearly Dividends per shareCRCT Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CRCT pays out 180.90% of its income as dividend. This is not a sustainable payout ratio.
DP180.9%
EPS Next 2Y-10.7%
EPS Next 3Y-3.97%
CRCT Yearly Income VS Free CF VS DividendCRCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M
CRCT Dividend Payout.CRCT Dividend Payout, showing the Payout Ratio.CRCT Dividend Payout.PayoutRetained Earnings

CRICUT INC - CLASS A

NASDAQ:CRCT (8/14/2025, 8:10:51 PM)

After market: 5.66 0 (0%)

5.66

+0.01 (+0.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners43.07%
Inst Owner Change2.15%
Ins Owners9.98%
Ins Owner Change-6.48%
Market Cap1.20B
Analysts40
Price Target4.06 (-28.27%)
Short Float %9.51%
Short Ratio8.03
Dividend
Industry RankSector Rank
Dividend Yield 3.6%
Yearly Dividend0.51
Dividend Growth(5Y)N/A
DP180.9%
Div Incr Years1
Div Non Decr Years1
Ex-Date07-07 2025-07-07 (0.75)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)59.22%
Min EPS beat(2)51.89%
Max EPS beat(2)66.55%
EPS beat(4)3
Avg EPS beat(4)39.3%
Min EPS beat(4)-0.47%
Max EPS beat(4)66.55%
EPS beat(8)6
Avg EPS beat(8)37.16%
EPS beat(12)7
Avg EPS beat(12)19.11%
EPS beat(16)7
Avg EPS beat(16)5.98%
Revenue beat(2)2
Avg Revenue beat(2)4%
Min Revenue beat(2)2.35%
Max Revenue beat(2)5.64%
Revenue beat(4)2
Avg Revenue beat(4)-0.27%
Min Revenue beat(4)-5.2%
Max Revenue beat(4)5.64%
Revenue beat(8)2
Avg Revenue beat(8)-3.79%
Revenue beat(12)4
Avg Revenue beat(12)-2.36%
Revenue beat(16)4
Avg Revenue beat(16)-4.26%
PT rev (1m)-2.87%
PT rev (3m)-2.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.19%
EPS NY rev (1m)0%
EPS NY rev (3m)22.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 17.15
Fwd PE 24.47
P/S 1.68
P/FCF 4.76
P/OCF 4.43
P/B 3.88
P/tB 3.88
EV/EBITDA 6.71
EPS(TTM)0.33
EY5.83%
EPS(NY)0.23
Fwd EY4.09%
FCF(TTM)1.19
FCFY21%
OCF(TTM)1.28
OCFY22.58%
SpS3.36
BVpS1.46
TBVpS1.46
PEG (NY)N/A
PEG (5Y)1.7
Profitability
Industry RankSector Rank
ROA 9.95%
ROE 23.25%
ROCE 25.71%
ROIC 17.73%
ROICexc N/A
ROICexgc N/A
OM 11.86%
PM (TTM) 10.09%
GM 52.14%
FCFM 35.35%
ROA(3y)7.54%
ROA(5y)12.63%
ROE(3y)10.84%
ROE(5y)24.18%
ROIC(3y)9.7%
ROIC(5y)21.39%
ROICexc(3y)22.43%
ROICexc(5y)43.81%
ROICexgc(3y)22.44%
ROICexgc(5y)44.35%
ROCE(3y)14.06%
ROCE(5y)31.02%
ROICexcg growth 3Y6.25%
ROICexcg growth 5Y9.03%
ROICexc growth 3Y6.37%
ROICexc growth 5Y9.43%
OM growth 3Y-9.61%
OM growth 5Y-0.51%
PM growth 3Y-6.41%
PM growth 5Y1.82%
GM growth 3Y12.23%
GM growth 5Y11.09%
F-Score7
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 72.96%
Cap/Sales 2.66%
Interest Coverage 250
Cash Conversion 245.12%
Profit Quality 350.45%
Current Ratio 1.52
Quick Ratio 1.21
Altman-Z 3.46
F-Score7
WACC8.88%
ROIC/WACC2
Cap/Depr(3y)89.12%
Cap/Depr(5y)121.3%
Cap/Sales(3y)3.16%
Cap/Sales(5y)2.9%
Profit Quality(3y)341.23%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.45%
EPS 3Y-23.19%
EPS 5Y10.11%
EPS Q2Q%22.22%
EPS Next Y-17.34%
EPS Next 2Y-10.7%
EPS Next 3Y-3.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.98%
Revenue growth 3Y-18.29%
Revenue growth 5Y7.93%
Sales Q2Q%2.48%
Revenue Next Year-4.46%
Revenue Next 2Y-1.68%
Revenue Next 3Y-0.44%
Revenue Next 5YN/A
EBIT growth 1Y-17.08%
EBIT growth 3Y-26.14%
EBIT growth 5Y7.38%
EBIT Next Year35.91%
EBIT Next 3Y14.57%
EBIT Next 5YN/A
FCF growth 1Y6.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.4%
OCF growth 3YN/A
OCF growth 5Y132.5%